152 related articles for article (PubMed ID: 18453785)
41. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
42. [Cerebrovascular disease in aged patients with polycythemia or thrombocythemia].
Akiguchi I; Shio H; Suzuki G; Kameyama M
Nihon Ronen Igakkai Zasshi; 1985 Mar; 22(2):93-9. PubMed ID: 4010043
[No Abstract] [Full Text] [Related]
43. The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
Hasselbalch HC
Leuk Res; 2014 Oct; 38(10):1230-6. PubMed ID: 25149709
[TBL] [Abstract][Full Text] [Related]
44. Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment.
Scharf RE
Hamostaseologie; 2016 Nov; 36(4):241-260. PubMed ID: 27414763
[TBL] [Abstract][Full Text] [Related]
45. Extreme thrombocytosis and cardiovascular surgery: risks and management.
Natelson EA
Tex Heart Inst J; 2012; 39(6):792-8. PubMed ID: 23304015
[TBL] [Abstract][Full Text] [Related]
46. [A case of dilated cardiomyopathy caused by myocardial microinfarcts in the course of polycythemia vera].
Konopka A; Stepińska J; Banaszewski M; Szajewski T
Pol Merkur Lekarski; 1998 Jan; 4(19):26-8. PubMed ID: 9583943
[TBL] [Abstract][Full Text] [Related]
47. An unusual case of toe ulceration.
Lankipalli R; Konkle B; Mohler ER
Vasc Med; 2006 Feb; 11(1):35-7. PubMed ID: 16669411
[TBL] [Abstract][Full Text] [Related]
48. Acute thrombotic complications of myeloproliferative disorders in young adults.
Davis RB
Am J Clin Pathol; 1985 Aug; 84(2):180-5. PubMed ID: 4025222
[TBL] [Abstract][Full Text] [Related]
49. Coronary vasculopathy in polycythemia vera.
Hermanns B; Handt S; Kindler J; Füzesi L
Pathol Oncol Res; 1998; 4(1):37-9. PubMed ID: 9555119
[TBL] [Abstract][Full Text] [Related]
50. [Unilateral internal cerebral vein thrombosis in MRI].
Wittkugel O; Lange R; Fiehler J
Rofo; 2004 Feb; 176(2):259-61. PubMed ID: 14872383
[No Abstract] [Full Text] [Related]
51. Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice.
Tefferi A; Barbui T
Mayo Clin Proc; 2015 Sep; 90(9):1283-93. PubMed ID: 26355403
[TBL] [Abstract][Full Text] [Related]
52. A Newly Characterized Hemoglobin Variant with a High Oxygen Affinity, Hb Fuchu-II, Presenting with Acute Myocardial Infarction.
Son R; Higuchi T; Mizuno A; Koyamada R; Okada S; Yamashiro Y
Intern Med; 2016; 55(3):285-7. PubMed ID: 26831025
[TBL] [Abstract][Full Text] [Related]
53. Essential thrombocythaemia and polycythaemia vera presenting with pulmonary embolism mimicing pneumonia. Case reports.
Björkholm M; Mellstedt H; Säwe U
Haematologica; 1981 Oct; 66(5):667-72. PubMed ID: 6796474
[No Abstract] [Full Text] [Related]
54. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
55. Hydroxyurea-induced stomatocytes in a patient presenting with polycythemia vera.
Perrin J; Ranta D; Lesesve JF
Am J Hematol; 2015 Jun; 90(6):573. PubMed ID: 25545052
[No Abstract] [Full Text] [Related]
56. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
58. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
59. Anagrelide: a new drug for treating thrombocytosis.
Silverstein MN; Petitt RM; Solberg LA; Fleming JS; Knight RC; Schacter LP
N Engl J Med; 1988 May; 318(20):1292-4. PubMed ID: 3362187
[TBL] [Abstract][Full Text] [Related]
60. Management of acute coronary syndromes clinical guideline.
SAMA/Acute Coronary Syndrome Working Group
S Afr Med J; 2001 Oct; 91(10 Pt 2):879-95. PubMed ID: 11757534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
